Bone Fragility Fractures in CKD Patients

Area of Science:

• Nephrology
• Endocrinology
• Orthopedics

Background:

• Chronic kidney diseases (CKD) are linked to mineral and bone disorders (MBD), causing pain, bone loss, and fractures.
• CKD-related bone fragility exacerbates osteoporosis risks, leading to increased fracture mortality.
• Lack of awareness and preventive strategies contribute to poor fracture management in CKD patients.

Purpose of the Study:

• To review the epidemiology and pathogenesis of CKD-associated bone loss.
• To discuss current and developing tools for evaluating fracture risk in CKD.
• To propose improved methods for predicting bone fragility and outline therapeutic options.

Main Methods:

• Literature review focusing on CKD-MBD, bone fragility, and fracture risk assessment.
• Analysis of current diagnostic tools including bone mineral density, biomarkers, and imaging.
• Discussion of emerging techniques and therapeutic strategies.

Main Results:

• CKD significantly elevates fracture risk beyond typical osteoporosis factors.
• Current guidelines recommend bone mineral density assessment when treatment decisions are influenced.
• A combination of bone density, biomarkers, and imaging aids fracture risk evaluation.

Conclusions:

• Better prediction of bone fragility in CKD is crucial for patient outcomes.
• Integrating current and novel assessment tools can improve fracture risk stratification.
• Optimized therapeutic strategies are needed to address bone fragility in CKD.